Asian Paints:2,625.20-5.52 (-0.21%)
Cipla:1,438.00+16.07 (+1.13%)
Eicher Motors:8,042.00+51.14 (+0.64%)
Nestle India:1,458.00-7.03 (-0.48%)
Grasim Inds:3,300.00+30.08 (+0.92%)
Hindalco Inds.:1,029.85-9.14 (-0.88%)
Hind. Unilever:2,028.00+7.27 (+0.36%)
ITC:271.65+4.59 (+1.72%)
Trent:2,970.00+17.13 (+0.58%)
Larsen & Toubro:4,081.00+39.61 (+0.98%)
M & M:3,424.80+9.90 (+0.29%)
Reliance Industries:1,313.20+2.23 (+0.17%)
Tata Consumer:1,056.30-11.75 (-1.10%)
Tata Motors PVeh:320.25-1.06 (-0.33%)
Tata Steel:183.50-0.50 (-0.27%)
Wipro:181.00+1.45 (+0.81%)
Apollo Hospitals:8,735.00-14.87 (-0.17%)
Dr Reddy's Labs:1,180.00+9.95 (+0.85%)
Titan Company:5,068.00+0.00 (+0.00%)
SBI:1,048.00-0.63 (-0.06%)
Shriram Finance:1,128.20+22.23 (+2.01%)
Bharat Electron:409.40+0.20 (+0.05%)
Kotak Mah. Bank:397.35+7.10 (+1.82%)
Infosys:1,130.00+10.19 (+0.91%)
Bajaj Finance:1,095.00+14.80 (+1.37%)
Adani Enterp.:2,994.90+4.49 (+0.15%)
Sun Pharma.Inds.:1,904.00+3.99 (+0.21%)
JSW Steel:1,299.70+13.89 (+1.08%)
HDFC Bank:725.05+5.04 (+0.70%)
TCS:2,298.00+8.93 (+0.39%)
ICICI Bank:1,411.90+9.95 (+0.71%)
Power Grid Corpn:264.80+1.29 (+0.49%)
Maruti Suzuki:13,809.00+119.10 (+0.87%)
Axis Bank:1,251.00+16.05 (+1.30%)
HCL Technologies:1,318.40-6.36 (-0.48%)
O N G C:238.50+0.50 (+0.21%)
NTPC:337.50+0.94 (+0.28%)
Coal India:402.50+2.52 (+0.63%)
Bharti Airtel:1,941.70+19.61 (+1.02%)
Tech Mahindra:1,592.10+2.23 (+0.14%)
Jio Financial:244.60+1.46 (+0.60%)
Adani Ports:1,696.00+14.13 (+0.84%)
HDFC Life Insur.:542.00+5.68 (+1.06%)
SBI Life Insuran:1,782.00+1.60 (+0.09%)
Max Healthcare:997.90+0.90 (+0.09%)
UltraTech Cem.:11,575.00+124.81 (+1.09%)
Bajaj Auto:11,793.00+147.89 (+1.27%)
Bajaj Finserv:2,016.00+4.02 (+0.20%)
Interglobe Aviat:5,165.00-28.04 (-0.54%)
Eternal:327.95+7.94 (+2.48%)
Asian Paints:2,625.20-5.52 (-0.21%)
Cipla:1,438.00+16.07 (+1.13%)
Eicher Motors:8,042.00+51.14 (+0.64%)
Nestle India:1,458.00-7.03 (-0.48%)
Grasim Inds:3,300.00+30.08 (+0.92%)
Hindalco Inds.:1,029.85-9.14 (-0.88%)
Hind. Unilever:2,028.00+7.27 (+0.36%)
ITC:271.65+4.59 (+1.72%)
Trent:2,970.00+17.13 (+0.58%)
Larsen & Toubro:4,081.00+39.61 (+0.98%)
M & M:3,424.80+9.90 (+0.29%)
Reliance Industries:1,313.20+2.23 (+0.17%)
Tata Consumer:1,056.30-11.75 (-1.10%)
Tata Motors PVeh:320.25-1.06 (-0.33%)
Tata Steel:183.50-0.50 (-0.27%)
Wipro:181.00+1.45 (+0.81%)
Apollo Hospitals:8,735.00-14.87 (-0.17%)
Dr Reddy's Labs:1,180.00+9.95 (+0.85%)
Titan Company:5,068.00+0.00 (+0.00%)
SBI:1,048.00-0.63 (-0.06%)
Shriram Finance:1,128.20+22.23 (+2.01%)
Bharat Electron:409.40+0.20 (+0.05%)
Kotak Mah. Bank:397.35+7.10 (+1.82%)
Infosys:1,130.00+10.19 (+0.91%)
Bajaj Finance:1,095.00+14.80 (+1.37%)
Adani Enterp.:2,994.90+4.49 (+0.15%)
Sun Pharma.Inds.:1,904.00+3.99 (+0.21%)
JSW Steel:1,299.70+13.89 (+1.08%)
HDFC Bank:725.05+5.04 (+0.70%)
TCS:2,298.00+8.93 (+0.39%)
ICICI Bank:1,411.90+9.95 (+0.71%)
Power Grid Corpn:264.80+1.29 (+0.49%)
Maruti Suzuki:13,809.00+119.10 (+0.87%)
Axis Bank:1,251.00+16.05 (+1.30%)
HCL Technologies:1,318.40-6.36 (-0.48%)
O N G C:238.50+0.50 (+0.21%)
NTPC:337.50+0.94 (+0.28%)
Coal India:402.50+2.52 (+0.63%)
Bharti Airtel:1,941.70+19.61 (+1.02%)
Tech Mahindra:1,592.10+2.23 (+0.14%)
Jio Financial:244.60+1.46 (+0.60%)
Adani Ports:1,696.00+14.13 (+0.84%)
HDFC Life Insur.:542.00+5.68 (+1.06%)
SBI Life Insuran:1,782.00+1.60 (+0.09%)
Max Healthcare:997.90+0.90 (+0.09%)
UltraTech Cem.:11,575.00+124.81 (+1.09%)
Bajaj Auto:11,793.00+147.89 (+1.27%)
Bajaj Finserv:2,016.00+4.02 (+0.20%)
Interglobe Aviat:5,165.00-28.04 (-0.54%)
Eternal:327.95+7.94 (+2.48%)
Arihant Plus App

Arihant Plus App

Mankind Pharma Ltd

Mankind Pharma | 543904

Market Closed
2,385.00
9.10 (-0.38%)
As on 21/08/26, 12:44 AM
Market Cap98,499.54 CR
Current Price₹2,385
High / Low₹2,674 / 1,909.7
PE Ratio1.05
Book Value₹16,301.46
Dividend Yield0.05%
ROCE12.97%
ROE13.27%
Face Value₹2.00
Current Vol.3,07,625
Average Vol.---
ISININE634S01028
PB Ratio0.12
Debt to Equity0.48
Net Profit Margin13.57
Operating Margin27.06

MANKIND - Share Price Chart

+0.00 (+0.00%)6M

Stock Performance

2,3942,413
2,385
Previous CloseToday's Open
1,909.72,674
2,385
52W Low52W High
₹2,413Today's Open
₹2,394Previous Close
3,07,625Volume
₹1,909.752W Low
₹2,67452W High

Ratios

No data available

About Company

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006
  • The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory
  • In 2004, the Company entered the chronic pharmaceutical segment with the launch of Amlokind' tablets and Glimestar' tablets amongst others
  • It set up their first manufacturing facility at Paonta Sahib, in Himachal Pradesh during year 2005
  • It entered the ophthalmic pharmaceutical segment with the launching of Lubistar Eye Drops' and Tobastar Eye Drops'
  • In 2007, the Company diversified into the consumer healthcare segment with the launch of Manforce' brand and have since established several differentiated brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral
  • supplements and anti-acne preparations categories
  • It entered into the business of animal healthcare segment and launched Bandykind' and Ceftiforce'

Ethics: Mankind Pharma Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

worldwide image

Adequate

The company demonstrates adequate ESG practices with room for improvement.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI40.92
SMA 202469.29
SMA 502478.11
SMA 1002374.33
SMA 2002275.75
SMA 102415.69
MACD_12_26_Days-30.06
EMA10Day2418.11
EMA20Day2447.58
EMA50Day2450.59
MACD_12_26_9_Days-10.84
EMA100Day2399.70
EMA200Day2363.46

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth16.96%
ROE12.65%
EBITDA Margin27.06%

All figures in ₹ Crores

Indicators20262025202420232022
Revenue
14,277.64
12,207.44
10,260.44
8,749.43
7,781.56
Interest
639.28
429.41
32.75
44.47
58.61
Expenses
10,660.23
9,189.51
7,746.76
6,848.80
5,792.20
Financing Profit
3,987.89
3,566.96
2,809.11
2,041.63
2,199.83
Financing Margin %
28%
29%
27%
23%
28%
Other Income
370.48
549.03
295.43
140.99
210.48
Depreciation
886.18
621.22
378.42
325.92
166.62
Profit before tax
2,332.68
2,516.33
2,397.94
1,671.24
1,974.60
Tax %
17%
20%
19%
22%
26%
Net Profit
1,938.10
2,006.59
1,940.79
1,309.68
1,452.96
EPS in Rs
46.35
49.28
47.75
32.00
35.78
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
GOLDMAN SACHS BANK EUROPE SE - ODI14 Oct ‘25Purchase55,0002,43012.76%
GOLDMAN SACHS (SINGAPORE) PTE - ODI14 Oct ‘25Sell55,0002,43012.76%
GOLDMAN SACHS BANK EUROPE SE - ODI13 Oct ‘25Purchase42,2452,44020.18%
GOLDMAN SACHS (SINGAPORE) PTE - ODI13 Oct ‘25Sell42,2452,44020.18%
AURIGIN MASTER FUND LIMITED10 Jul ‘24Purchase48,0322,0822.51%
SOCIETE GENERALE10 Jul ‘24Purchase1,20,0782,0826.29%
CITIGROUP GLOBAL MARKETS MAURITIUS PRIVATE LIMITED (ODI)10 Jul ‘24Purchase48,0322,0822.51%
CITIGROUP GLOBAL MARKETS MAURITIUS PVT LTD10 Jul ‘24Purchase96,0632,0825.03%
COPTHALL MAURITIUS INVESTMENT LTD10 Jul ‘24Purchase48,0322,0822.51%
GHISALLO MASTER FUND LP10 Jul ‘24Purchase1,06,0322,0825.55%

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
04 Aug 2026
AGM
AGM
30 Jun 2026
08 Aug 2025
Interim Dividend (₹1)
approved the payment of interim dividend of ? 1/- per equity share i.e. 100% on face value of ? 1/- per equity share for the Financial Year 2025-26 and in terms of Regulation 42 of the Listing Regulations, Board has fixed Friday, August 8, 2025, as the 'Record Date' for the purpose of ascertaining the eligibility of shareholders for payment of interim dividend. Same would be paid within 30 days from the date of declaration.
31 Jul 2025
07 Aug 2025
AGM
AGM
03 Jul 2025
09 Aug 2024
AGM
AGM
18 Jul 2024
22 Sept 2023
AGM
AGM
24 Aug 2023

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
2,385
98,500
46
6
33
0
13.57%
1,901
4,56,114
36
5
29
0
19.78%
8,587
2,27,958
77
14
66
0
24.32%
4,995
1,89,990
85
23
51
1
11.09%
1,438
1,16,141
32
3
24
0
9.92%
1,109
1,10,603
23
4
17
0
9.82%
2,203
1,00,733
17
4
13
0
19.16%
1,181
98,604
31
3
18
0
12.34%
1,823
98,499
90
19
62
1
13.06%
1,606
93,300
25
2
17
0
10.41%
Showing 10 of 138 Results

Frequently Asked Questions

What is Share Price of Mankind Pharma Ltd?

The current share price of Mankind Pharma Ltd (Mankind Pharma) is ₹2385.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Mankind Pharma Ltd?

The Price-to-Earnings (P/E) ratio of Mankind Pharma Ltd is 2385.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Mankind Pharma Ltd?

Mankind Pharma Ltd has a 52-week high of ₹2674.00 and a 52-week low of ₹1909.70. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Mankind Pharma Ltd?

Mankind Pharma Ltd offers a dividend yield of 0.04%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Mankind Pharma Ltd?

The Earnings Per Share (EPS) of Mankind Pharma Ltd is ₹51.66. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Mankind Pharma Ltd?

Mankind Pharma Ltd has a Return on Equity (ROE) of 13.27%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2